• Home
  • BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.

BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.

Author List
Leyte-Vidal A, Garrido Ruiz D, DeFilippis R, Leske IB, Rea D, Phan S, Miller KB, Hu F, Mase A, Shan Y, Hantschel O, Jacobson MP, Shah NP
Publication
Blood
Publication ID (Profile URL)
https://researcherprofiles.org/profile/521980240
Publication Year
2024
PubMed ID
38643492
Publication Title
Leyte-Vidal A, Garrido Ruiz D, DeFilippis R, Leske IB, Rea D, Phan S, Miller KB, Hu F, Mase A, Shan Y, Hantschel O, Jacobson MP, Shah NP. BCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib. Blood. 2024 08 08; 144(6):639-645.